Sale, United Kingdom

Mike Galvin

This inventor holds 1 USPTO granted patent. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mike Galvin. Retrieved from https://idiyas.com/inventor/mike-galvin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mike Galvin

Introduction

Mike Galvin is a notable inventor based in Sale, GB. He has made significant contributions to the field of medical technology. His most recognized invention is a medical oxygen concentrator, which has the potential to improve the quality of life for many patients requiring oxygen therapy.

Latest Patents

Mike Galvin holds 1 patent for his innovative medical oxygen concentrator. This device is designed to efficiently provide oxygen to patients, making it a crucial tool in medical settings.

Career Highlights

Throughout his career, Mike has focused on developing technologies that enhance patient care. His dedication to innovation in the medical field has earned him recognition among his peers.

Collaborations

Mike has collaborated with several talented individuals, including Fred Galvin and Christopher David Phillips. These partnerships have contributed to the success of his inventions and the advancement of medical technology.

Conclusion

Mike Galvin's work in developing a medical oxygen concentrator showcases his commitment to improving healthcare through innovation. His contributions are valuable to the medical community and highlight the importance of inventors in advancing technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…